RNXTRenovoRx, Inc.vs its industry peers
A metric-by-metric comparison of RenovoRx, Inc. against SIC 2834 — valuation, growth, profitability, quality and total return, with each figure's rank within the peer group. Every value is Go-computed from SEC filings and delayed prices; ranks are sorted positions within the group only — descriptive, not advice.
| Empresa | Market cap | P/E (TTM) | P/B | P/S | Revenue growth (YoY) | Earnings growth (YoY) | EBIT margin | ROE | ROIC | Piotroski F | 1y total return | Dividend yield |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| RNXTEsta | $48M#6 | — | 4.3x#3 | 42.8x#3 | 2511.6%#1 | -26.7%#4 | -1114.0%#3 | -99.1%#3 | — | — | -14.1%#1 | — |
| XLO | $52M#3 | — | 0.7x#1 | 1.2x#1 | 589.9%#2 | 39.8%#2 | -95.9%#1 | -48.3%#1 | — | — | — | — |
| NMAD | $53M#2 | — | 6.7x#5 | 265.6x#4 | — | -69.5%#5 | -2553.8%#4 | -76.5%#2 | — | — | — | — |
| IBO | $49M#4 | — | 4.3x#4 | 1533.8x#6 | — | 52.1%#1 | -13381.3%#5 | -103.3%#4 | -18.3%#1 | — | -28.7%#2 | — |
| FLNA | $49M#5 | — | 0.7x#2 | 1.2x#2 | 277.6%#3 | -273.7%#6 | -232.0%#2 | -133.5%#5 | — | — | — | — |
| INO | $57M#1 | — | 9.5x#6 | 878.5x#5 | -70.0%#4 | 20.6%#3 | -132871.3%#6 | -1400.8%#6 | -204.0%#2 | — | — | — |
Peer set: US filers sharing this company's SEC industry classification (SIC 2834). SIC is coarse — conglomerates and multi-segment companies map imperfectly. Values from SEC filings + delayed prices; ranks are within-group positions only. Market cap, P/E, P/B, P/S, 1y total return and dividend yield are computed from each member's latest snapshot price when the table is built (see as-of; snapshot prices can lag) — not live. Some peers are still being computed, so this table covers part of the group and ranks are within the rows shown; it fills in shortly. Esta tabla agotó el tiempo durante su construcción, por lo que cubre parte del grupo; los rangos son solo dentro de las filas mostradas y se completará en breve. Table built 2026-08-04.
Source: SEC XBRL filings + delayed prices · ranks are within-group positions · For reference only · Not investment advice